Form EFFECT Inozyme Pharma, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 1, 2025 |
| Accession Number: | 0001193125-25-153585 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Best Infrared Saunas of 2026 [Expert Reviewed and Independently Verified]
- 3D AI Studio Launches Flow: Node-Based 3D Workflows That Run in the Browser With No GPU or Setup
- Don't Miss the Next HBAR: The Best Crypto Presale to Buy in 2026 Revealed
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
